癌症免疫治疗中的新抗原:数量与质量对比
Yochai Wolf1,2, Yardena Sameuls3
1Ella Lemelbaum Institute for Immuno-oncology, Sheba Medical Center, Ramat Gan, Israel.
Molecular oncology
|June 28, 2023
概括
基于新抗原的癌症免疫疗法显示出希望,但需要比数量更深入的理解. 像新抗原类型和克隆性这样的定性因素对于预测患者的反应和提高治疗效果至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 传统的免疫疗法对固体瘤具有有限的临床益处.
- 目前的免疫疗法取决于癌症抗原的呈现,新抗原是关键.
- 新抗原数量与治疗成功相关,但不能完全预测治疗成功.
研究的目的:
- 探索超越单纯数量的新抗原的定性方面.
- 增强对基于新抗原的免疫疗法策略的理解.
- 确定影响患者对新抗原向疗法的反应的因素.
主要方法:
- 对癌症免疫疗法中新抗原的当前研究进行审查和综合.
- 分析定性新抗原特征,包括私有与经常性新抗原的分析.
- 讨论新抗原克隆性和新类型的新亚型.
主要成果:
- 仅仅是新抗原的数量不足以预测免疫治疗的结果.
- 区分私有和经常性新抗原提供了更深入的见解.
- 新抗原的克隆性和新的新子类型代表了关键的定性因素.
结论:
- 对新抗原的定性评估对于推进癌症免疫疗法至关重要.
- 考虑超越数量的新抗原特征可以提高治疗疗效.
- 对新抗原亚型和克隆性的进一步研究将使免疫疗法潜力多样化.
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Cancer Vaccines
433
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
433
Antigens Involved in Adaptive Immunity
563
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
563


